KR100353262B1 - 위궤양의 예방 및 치료에 효과가 있는 소엽 추출물의 제조방법과 그 용도 및 그로부터 버베린을 얻는 공정 - Google Patents
위궤양의 예방 및 치료에 효과가 있는 소엽 추출물의 제조방법과 그 용도 및 그로부터 버베린을 얻는 공정 Download PDFInfo
- Publication number
- KR100353262B1 KR100353262B1 KR1020000013074A KR20000013074A KR100353262B1 KR 100353262 B1 KR100353262 B1 KR 100353262B1 KR 1020000013074 A KR1020000013074 A KR 1020000013074A KR 20000013074 A KR20000013074 A KR 20000013074A KR 100353262 B1 KR100353262 B1 KR 100353262B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- leaflet
- berberine
- pylori
- organic solvent
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 122
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 title claims abstract description 37
- 229940093265 berberine Drugs 0.000 title claims abstract description 37
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 title claims abstract description 37
- 230000002265 prevention Effects 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 title claims abstract description 22
- 208000007107 Stomach Ulcer Diseases 0.000 title claims abstract description 17
- 201000005917 gastric ulcer Diseases 0.000 title claims abstract description 15
- 230000000694 effects Effects 0.000 title claims description 67
- 230000008569 process Effects 0.000 title abstract description 5
- 235000004347 Perilla Nutrition 0.000 title 1
- 241000229722 Perilla <angiosperm> Species 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 54
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 51
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 27
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 24
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000003960 organic solvent Substances 0.000 claims abstract description 22
- 238000004519 manufacturing process Methods 0.000 claims abstract description 19
- 239000004480 active ingredient Substances 0.000 claims abstract description 17
- 238000004440 column chromatography Methods 0.000 claims abstract description 12
- 210000002919 epithelial cell Anatomy 0.000 claims abstract description 9
- 230000021995 interleukin-8 production Effects 0.000 claims abstract description 9
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 9
- 238000012746 preparative thin layer chromatography Methods 0.000 claims abstract description 7
- 239000006049 herbal material Substances 0.000 claims abstract description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 42
- 241000590002 Helicobacter pylori Species 0.000 claims description 32
- 229940037467 helicobacter pylori Drugs 0.000 claims description 31
- 108010046334 Urease Proteins 0.000 claims description 27
- 230000000845 anti-microbial effect Effects 0.000 claims description 24
- 239000000463 material Substances 0.000 claims description 21
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 17
- 238000000605 extraction Methods 0.000 claims description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- 239000012153 distilled water Substances 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 9
- 235000015140 cultured milk Nutrition 0.000 claims description 8
- 230000001225 therapeutic effect Effects 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims 1
- 238000004821 distillation Methods 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000008177 pharmaceutical agent Substances 0.000 claims 1
- 238000003809 water extraction Methods 0.000 abstract description 7
- HACSKNCIFXREIE-UHFFFAOYSA-N butanoic acid;ethoxyethane Chemical compound CCOCC.CCCC(O)=O HACSKNCIFXREIE-UHFFFAOYSA-N 0.000 abstract 1
- HTRXGEPDTFSKLI-UHFFFAOYSA-N butanoic acid;ethyl acetate Chemical compound CCCC(O)=O.CCOC(C)=O HTRXGEPDTFSKLI-UHFFFAOYSA-N 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 34
- 241000589989 Helicobacter Species 0.000 description 20
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 20
- 239000002609 medium Substances 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 241000894006 Bacteria Species 0.000 description 16
- 208000015181 infectious disease Diseases 0.000 description 16
- 102000004890 Interleukin-8 Human genes 0.000 description 15
- 108090001007 Interleukin-8 Proteins 0.000 description 15
- 239000002994 raw material Substances 0.000 description 15
- 238000010586 diagram Methods 0.000 description 13
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 238000005259 measurement Methods 0.000 description 12
- 206010019375 Helicobacter infections Diseases 0.000 description 11
- 230000000844 anti-bacterial effect Effects 0.000 description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 10
- 238000011534 incubation Methods 0.000 description 10
- 230000005764 inhibitory process Effects 0.000 description 10
- XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 10
- 229940096397 interleukin-8 Drugs 0.000 description 10
- 239000004310 lactic acid Substances 0.000 description 10
- 235000014655 lactic acid Nutrition 0.000 description 10
- 238000004809 thin layer chromatography Methods 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 9
- 239000000872 buffer Substances 0.000 description 9
- 230000002496 gastric effect Effects 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 238000000926 separation method Methods 0.000 description 9
- 229920001817 Agar Polymers 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 8
- 239000008272 agar Substances 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 239000008187 granular material Substances 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 241000589562 Brucella Species 0.000 description 7
- 241000186660 Lactobacillus Species 0.000 description 7
- 239000011149 active material Substances 0.000 description 7
- 239000013543 active substance Substances 0.000 description 7
- 235000010633 broth Nutrition 0.000 description 7
- 210000004051 gastric juice Anatomy 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 238000001228 spectrum Methods 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- 208000007882 Gastritis Diseases 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 239000006285 cell suspension Substances 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 235000008504 concentrate Nutrition 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 229940039696 lactobacillus Drugs 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 241000186000 Bifidobacterium Species 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000000069 prophylactic effect Effects 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 238000005084 2D-nuclear magnetic resonance Methods 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 239000004202 carbamide Substances 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 239000000287 crude extract Substances 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000007902 hard capsule Substances 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 239000012086 standard solution Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 3
- XILIYVSXLSWUAI-UHFFFAOYSA-N 2-(diethylamino)ethyl n'-phenylcarbamimidothioate;dihydrobromide Chemical compound Br.Br.CCN(CC)CCSC(N)=NC1=CC=CC=C1 XILIYVSXLSWUAI-UHFFFAOYSA-N 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 238000002768 Kirby-Bauer method Methods 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000012223 aqueous fraction Substances 0.000 description 3
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 238000005100 correlation spectroscopy Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 102000038379 digestive enzymes Human genes 0.000 description 3
- 108091007734 digestive enzymes Proteins 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000003651 drinking water Substances 0.000 description 3
- 235000020188 drinking water Nutrition 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 238000003919 heteronuclear multiple bond coherence Methods 0.000 description 3
- 238000003929 heteronuclear multiple quantum coherence Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000003449 preventive effect Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 238000012584 2D NMR experiment Methods 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 244000199866 Lactobacillus casei Species 0.000 description 2
- 235000013958 Lactobacillus casei Nutrition 0.000 description 2
- 208000008469 Peptic Ulcer Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 241000194020 Streptococcus thermophilus Species 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 231100000676 disease causative agent Toxicity 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 210000001156 gastric mucosa Anatomy 0.000 description 2
- 231100000029 gastro-duodenal ulcer Toxicity 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 229940017800 lactobacillus casei Drugs 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000002032 methanolic fraction Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 239000006152 selective media Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 239000011675 vitamin B5 Substances 0.000 description 2
- 235000009492 vitamin B5 Nutrition 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 229930008281 A03AD01 - Papaverine Natural products 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000006000 Garlic extract Substances 0.000 description 1
- 206010017886 Gastroduodenal ulcer Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 241000590017 Helicobacter felis Species 0.000 description 1
- 101001055222 Homo sapiens Interleukin-8 Proteins 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 235000006964 Perilla frutescens var acuta Nutrition 0.000 description 1
- 240000001979 Perilla frutescens var. acuta Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- -1 and finally Substances 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229940009291 bifidobacterium longum Drugs 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 230000016396 cytokine production Effects 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000007905 drug manufacturing Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 235000019985 fermented beverage Nutrition 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000000576 food coloring agent Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000020706 garlic extract Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000011491 glass wool Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 235000021579 juice concentrates Nutrition 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- COTNUBDHGSIOTA-UHFFFAOYSA-N meoh methanol Chemical compound OC.OC COTNUBDHGSIOTA-UHFFFAOYSA-N 0.000 description 1
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960001789 papaverine Drugs 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229930193017 perilloside Natural products 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (11)
- 삭제
- 삭제
- 헬리코박터 필로리에 대한 항균활성 및 헬리코박터 필로리 우레아제활성 억제효과, 위상피세포 정착성 억제효과, 인터루킨-8 생성억제효과를 갖도록 생약소재인 소엽에 물이 상기 소엽 중량에 대해 약5∼20배 첨가되고, 90∼98℃에서 6∼15시간동안 열수추출하고 40∼70cmHg로 감압농축하는 열수추출법으로 위궤양 예방 및 치료효과를 가지는 것을 특징으로 하는 소엽추출물의 제조방법.
- 삭제
- 삭제
- 제 3항의 제조방법으로 제조된 소엽추출물을 유효성분으로 함유하는 것을 특징으로 하는 위궤양 예방 및 치료효과가 있는 발효유.
- 제 3항의 제조방법으로 제조된 추출물을 유효성분으로 함유하는 것을 특징으로 하는 위궤양 예방 및 치료효과가 있는 음료.
- 제 3항의 제조방법으로 제조된 추출물을 유효성분으로 함유하고, 여기에 약제학적으로 허용되는 부형제 및 보조제를 혼합하여 약제학적으로 허용되는 방법으로 제형화한 위궤양 예방 및 치료효과가 있는 약학 제제.
- 소엽 추출물에 증류수(물)와 유기용매를 가하여 혼합하는 혼합단계 및;상기 유기 용매에 대한 물질의 용해도와 극성의 차를 이용하여 소엽 추출물내의 물질들을 수용층과 유기용매층으로 분리하는 유기용매에 의한 수용액 물질의 분획단계;상기 수용층을 여과지로 여과하여 침전물을 제거한 되 감압 농축하고 다시 증류주를 가하여 추출용액(extract solution)을 제조한 뒤 상기 추출 용액을 XAD-7 칼럼 크로마토그래피에 넣는 XAD-7 칼럼 크로마토그래피(XAD-7 Column chromatography)단계;아세톤과 메탄올을 가하여 유기 용매 용출액을 얻고 상기 유기 용매 용출액을 실리카 칼럼 크로마토그래피(silica column chromatography)를 이용하여 분획액을 얻는 단계;상기 분획액을 예비 TLC(preparative)를 이용하여 버베린을 분리하는 것을 단계를 포함하는 것을 특징으로 하는 위궤양 예방 및 치료효과를 갖는 버베린 추출방법.
- 제 9항에 있어서, 상기 유기 용매는 클로로포름(chloroform), 디클로로메탄(dichloromethane), 디에틸 에테르(diethyl ether), 및 에틸 아세테이트(ethyl acetate)로 이루어지는 군으로부터 선택되어 지는 것을 특징으로 하는 위궤양 예방 및 치료효과를 갖는 버베린 추출방법.
- 제 9항의 버베린 추출방법에 의해서 얻어진 버베린을 유효성분으로 함유하고, 여기에 약제학적으로 허용되는 부형제 및 보조제를 혼합하여 약제학적으로 허용되는 방법으로 제형화한 위궤양 예방, 치료효과가 있는 약학 제제.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020000013074A KR100353262B1 (ko) | 2000-03-15 | 2000-03-15 | 위궤양의 예방 및 치료에 효과가 있는 소엽 추출물의 제조방법과 그 용도 및 그로부터 버베린을 얻는 공정 |
JP2001045047A JP4888750B2 (ja) | 2000-03-15 | 2001-02-21 | 胃潰瘍の予防及び治療に効果的な蘇葉抽出物とその用途及びその抽出物からベルベリンを得る工程 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020000013074A KR100353262B1 (ko) | 2000-03-15 | 2000-03-15 | 위궤양의 예방 및 치료에 효과가 있는 소엽 추출물의 제조방법과 그 용도 및 그로부터 버베린을 얻는 공정 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010100198A KR20010100198A (ko) | 2001-11-14 |
KR100353262B1 true KR100353262B1 (ko) | 2002-09-18 |
Family
ID=19655430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020000013074A KR100353262B1 (ko) | 2000-03-15 | 2000-03-15 | 위궤양의 예방 및 치료에 효과가 있는 소엽 추출물의 제조방법과 그 용도 및 그로부터 버베린을 얻는 공정 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP4888750B2 (ko) |
KR (1) | KR100353262B1 (ko) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100512403B1 (ko) * | 2002-05-23 | 2005-09-07 | 송도원 | 차조기 추출액의 제조방법 |
KR100506955B1 (ko) * | 2002-05-23 | 2005-08-11 | 송도원 | 참깨 추출액의 제조방법 |
KR100496146B1 (ko) * | 2002-06-12 | 2005-06-20 | 주식회사 뉴로넥스 | 감초, 강황 및 소엽의 추출물을 함유한 위염 및 위궤양의예방 및 치료를 위한 조성물 |
KR100892180B1 (ko) * | 2007-04-23 | 2009-04-10 | 강릉원주대학교산학협력단 | 귤껍질 분말 또는 이의 추출물을 함유하는 위장 질환 예방및 치료용 조성물 |
CN102215852B (zh) * | 2008-10-30 | 2014-06-11 | 国立大学法人琉球大学 | 抗幽门螺杆菌活性剂 |
KR101127675B1 (ko) | 2009-09-28 | 2012-03-22 | 영남대학교 산학협력단 | 차조기 추출액 및 이를 이용한 음료 |
KR20140033998A (ko) * | 2012-09-11 | 2014-03-19 | 씨제이제일제당 (주) | 사이코사포닌 a, 베르베린 및 리코이소플라본 b를 포함하는 위장질환의 예방 또는 치료용 조성물 |
CN103254189B (zh) * | 2013-04-23 | 2015-11-04 | 广西民族大学 | 应用盐酸小檗碱分子印迹色谱柱分离盐酸小檗碱的方法 |
CA2916972A1 (en) * | 2013-07-18 | 2015-01-22 | Amino Up Chemical Co., Ltd. | A composition having a prebiotic effect |
KR101650522B1 (ko) | 2014-11-03 | 2016-08-25 | 경상북도(농업기술원) | 자소로부터 미리스티신을 추출하는 방법 |
CN109187841B (zh) * | 2018-08-31 | 2020-11-13 | 成都大学 | 黄连花的薄层鉴别方法 |
CN112684093B (zh) * | 2020-12-08 | 2022-11-25 | 广西中医药大学 | 一种十一方药酒的质量检测方法 |
KR102416803B1 (ko) * | 2021-12-21 | 2022-07-05 | 주식회사 유담 | 배치식 살균과 후살균 공정을 이용한 상온유통 스파우트 파우치 포장 식물성 발효 유산균 음료 개발 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3059795B2 (ja) * | 1991-08-27 | 2000-07-04 | 鐘紡株式会社 | 精神安定用食品 |
US5340833A (en) * | 1992-05-01 | 1994-08-23 | Eisai Co., Ltd. | Urokinase inhibitors |
JP3547782B2 (ja) * | 1993-12-28 | 2004-07-28 | ロート製薬株式会社 | 抗ヘリコバクター・ピロリ活性剤 |
JPH08295632A (ja) * | 1995-03-02 | 1996-11-12 | Takeda Chem Ind Ltd | 抗菌剤 |
JPH0987189A (ja) * | 1995-09-19 | 1997-03-31 | Ichimaru Pharcos Co Ltd | エンメイソウ、ボタンピ、シソ、アルニカ含有抗アレルギー剤 |
JP3326589B2 (ja) * | 1996-10-26 | 2002-09-24 | 祥之 亀山 | 桑葉、梅肉、梅仁、紫蘇葉等を素材とする健康食品 |
-
2000
- 2000-03-15 KR KR1020000013074A patent/KR100353262B1/ko active IP Right Review Request
-
2001
- 2001-02-21 JP JP2001045047A patent/JP4888750B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
KR20010100198A (ko) | 2001-11-14 |
JP2001270835A (ja) | 2001-10-02 |
JP4888750B2 (ja) | 2012-02-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100353262B1 (ko) | 위궤양의 예방 및 치료에 효과가 있는 소엽 추출물의 제조방법과 그 용도 및 그로부터 버베린을 얻는 공정 | |
KR101625262B1 (ko) | 레보캐리마이신, 약학 조성물, 제조방법 및 응용 | |
JP2023507704A (ja) | 菌株をベースとする組成物および抗炎症剤としてのその使用 | |
JP2023507048A (ja) | 菌株およびベリーエキスをベースとする組成物ならびに抗炎症剤としてのその使用 | |
JP7395622B2 (ja) | 新規なフィーカリバクテリウムプラウスニッツィイ菌株eb-fpdk11およびその用途 | |
KR101409194B1 (ko) | 에쿠올 농도 조절제 | |
KR100996056B1 (ko) | 대장염 발생 예방 효능을 가진 락토바실러스 브레비스에이치와이7401 및 이를 유효성분으로 함유하는 제품 | |
CN111548954B (zh) | 四种蒽醌类化合物及其制备方法和用途 | |
Chaleshtori et al. | Antibacterial effects of the methanolic extract of Glycine Max (Soybean) | |
KR101689746B1 (ko) | 프로바이오틱스로 사용될 수 있는 신규 유산균 및 이의 용도 | |
WO2010131910A2 (ko) | 발효차를 함유하는 혈액 순환 개선용 조성물 및 이를 포함하는 약제학적 및 건강 식품 조성물 | |
KR20130114942A (ko) | 신규한 바실러스 서브틸리스 bcnu 9169 균주 및 이를 유효성분으로 포함하는 생균제 조성물 | |
KR101142598B1 (ko) | 다시마 정유 추출물 또는 이로부터 분리된 화합물을 유효성분으로 함유하는 항균 조성물 | |
CN117143769A (zh) | 一株既能转化甘草酸又能转化芦丁和大豆苷的植物乳植杆菌ccfm1275 | |
CN109985027B (zh) | 杨梅醇在制备抗革兰阴性细菌毒力药物中的应用 | |
CN116747245A (zh) | 动物双歧杆菌乳亚种bx-245在抑菌和/或生产功能活性物质中的应用 | |
KR101882475B1 (ko) | 베타-글루코시다제 활성을 갖는 신규 유산균 및 이의 용도 | |
KR101077202B1 (ko) | 감잎으로부터 추출된 헬리코박터 파이로리균에 대한 항균성추출물 | |
JP7479521B2 (ja) | 新規なフィーカリバクテリウムプラウスニッツィイeb-fpdk9菌株およびその用途 | |
KR101644607B1 (ko) | 흑미 추출물을 유효성분으로 함유하는 헬리코박터 파이로리 유래 질환의 예방 또는 치료용 약학적 조성물 및 건강식품 | |
KR20180120933A (ko) | 류코노스톡 메센테로이데스 신균주 및 이를 이용해 제조한 브로컬리 발효물을 유효성분으로 포함하여 대장염 예방, 치료 또는 개선 기능을 갖는 조성물 | |
KR102177552B1 (ko) | 락토바실러스 프란타룸 g72 균주를 포함하는 위장관 질환 예방 또는 치료용 조성물 | |
KR101376629B1 (ko) | 신규한 락토바실러스 아리조넨시스 bcnu 9200 균주 및 이를 유효성분으로 포함하는 생균제 조성물 | |
KR101783673B1 (ko) | 유아 분변에서 분리한 균주 및 이를 이용한 항산화 기능을 갖는 발효유의 제조방법 | |
KR102506366B1 (ko) | 락토바실러스 플란타럼 ku15120 균주 또는 이의 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120905 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20130906 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20140905 Year of fee payment: 13 |
|
J204 | Request for invalidation trial [patent] | ||
J301 | Trial decision |
Free format text: TRIAL DECISION FOR INVALIDATION REQUESTED 20141008 Effective date: 20150331 |
|
J121 | Written withdrawal of request for trial | ||
FPAY | Annual fee payment |
Payment date: 20150904 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20160906 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20170904 Year of fee payment: 16 |
|
FPAY | Annual fee payment |
Payment date: 20180905 Year of fee payment: 17 |
|
FPAY | Annual fee payment |
Payment date: 20190902 Year of fee payment: 18 |